SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008087
Filing Date
2023-05-04
Accepted
2023-05-04 16:04:19
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20230331x10q.htm   iXBRL 10-Q 1743383
2 EX-31.1 coll-20230331xex31d1.htm EX-31.1 13074
3 EX-31.2 coll-20230331xex31d2.htm EX-31.2 13098
4 EX-32.1 coll-20230331xex32d1.htm EX-32.1 7653
5 EX-32.2 coll-20230331xex32d2.htm EX-32.2 7491
6 GRAPHIC coll-20230331x10q001.jpg GRAPHIC 9164
  Complete submission text file 0001558370-23-008087.txt   8778022

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20230331.xsd EX-101.SCH 62850
8 EX-101.CAL coll-20230331_cal.xml EX-101.CAL 77989
9 EX-101.DEF coll-20230331_def.xml EX-101.DEF 263785
10 EX-101.LAB coll-20230331_lab.xml EX-101.LAB 532126
11 EX-101.PRE coll-20230331_pre.xml EX-101.PRE 418292
79 EXTRACTED XBRL INSTANCE DOCUMENT coll-20230331x10q_htm.xml XML 1704430
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 23888548
SIC: 2834 Pharmaceutical Preparations